Sorted By Test Name - Mayo Medical Laboratories

89027
KIDBN
82619
Reference Values:
Reporting limit determined each analysis
Synonym(s): Nizoral
Peak plasma levels of 5.4 +/- 1.7 mcg/mL occurred at
approximately 1 hour following a single 200 mg dose and peak
plasma levels of 22 +/- 3 mcg/mL occurred at approximately
2 hours following a single 800 mg dose of ketoconazole.
Test Performed by: NMS Labs
3701 Welsh Road
P.O. Box 433A
Willow Grove, PA 19090-0437
Ki-67(MIB-1), Quantitative Immunohistochemistry, Automated
Clinical Information: Ki-67(MIB-1 clone) is a monoclonal antibody that reacts with cells
undergoing DNA synthesis by binding to the Ki-67 antigen, a marker known to be expressed only in
proliferating cells. By measuring the amount of tumor cells expressing Ki-67, an estimate of DNA
synthesis can be determined. Studies suggest that Ki-67(MIB-1) analysis of paraffin-embedded tissue
specimens may provide useful prognostic information in various tumor types.
Useful For: Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients
diagnosed with breast or prostate carcinoma
Interpretation: Results will be reported as a percentage of tumor cells staining positive for
Ki-67(MIB-1). Quantitative Ki-67(MIB-1) results should be interpreted within the clinical context for
which the test was ordered. For prostate biopsy cancer specimens: when this test is ordered in conjunction
with digital image analysis, 80948 DNA Ploidy by Digital Image Analysis (DIA), Paraffin Block,
Ki-67(MIB-1) results are reported as a low (